A contemporary review of male breast cancer: current evidence and unanswered questions
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A contemporary review of male breast cancer: current evidence and unanswered questions
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-19
DOI
10.1007/s10555-018-9761-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
- (2017) Marijn A. Vermeulen et al. EUROPEAN JOURNAL OF CANCER
- Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis
- (2017) Matthew J. Abrams et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
- (2017) Armando E. Giuliano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
- (2017) Carolyn Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Breast Cancer, Version 1.2017
- (2017) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
- (2017) Charlotte E Coles et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.
- (2017) Richard G. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer
- (2016) Tina J. Hieken et al. ANNALS OF SURGICAL ONCOLOGY
- Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis
- (2016) Piera Gargiulo et al. BMC CANCER
- Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
- (2016) Mary Pritzlaff et al. BREAST CANCER RESEARCH AND TREATMENT
- The Genomic Landscape of Male Breast Cancers
- (2016) Salvatore Piscuoglio et al. CLINICAL CANCER RESEARCH
- 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
- (2016) Vratislav Strnad et al. LANCET
- Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Arlene Chan et al. LANCET ONCOLOGY
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes
- (2016) Francesco Giotta et al. ONCOLOGIST
- Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer
- (2015) G. Pruneri et al. ANNALS OF ONCOLOGY
- Prognostic significance of tumor subtypes in male breast cancer: a population-based study
- (2015) José Pablo Leone et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor and antiandrogen therapy in male breast cancer
- (2015) Luigi Di Lauro et al. CANCER LETTERS
- SEOM clinical guidelines in Hereditary Breast and ovarian cancer
- (2015) G. Llort et al. Clinical & Translational Oncology
- Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
- (2015) K. Elebro et al. CLINICAL CANCER RESEARCH
- Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
- (2015) Luigi Di Lauro et al. Journal of Hematology & Oncology
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
- (2015) Harry Bartelink et al. LANCET ONCOLOGY
- Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
- (2015) Ian H Kunkler et al. LANCET ONCOLOGY
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series
- (2014) Luigi Di Lauro et al. BREAST CANCER RESEARCH AND TREATMENT
- Fulvestrant and male breast cancer: a pooled analysis
- (2014) Flora Zagouri et al. BREAST CANCER RESEARCH AND TREATMENT
- The use of everolimus to reverse tamoxifen resistance in men with metastatic breast cancer: a case report
- (2014) Joseph Kattan et al. INVESTIGATIONAL NEW DRUGS
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
- (2014) Mila Donker et al. LANCET ONCOLOGY
- The 21-Gene Recurrence Score Assay (Oncotype DX) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort
- (2014) Tal Grenader et al. ONCOLOGY
- Male breast cancer networking and telephone support group: a model for supporting a unique population
- (2014) Elizabeth Farrell et al. PSYCHO-ONCOLOGY
- Treatment Techniques to Reduce Cardiac Irradiation for Breast Cancer Patients Treated with Breast-Conserving Surgery and Radiation Therapy: A Review
- (2014) Robert E. Beck et al. Frontiers in Oncology
- Quality of life and symptoms in male breast cancer survivors
- (2013) Kathryn J. Ruddy et al. BREAST
- An update on male breast cancer and future directions for research and treatment
- (2013) Berta Sousa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Management of Male Breast Cancer in the United States: A Surveillance, Epidemiology and End Results Analysis
- (2013) Emma C. Fields et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Proton Therapy for Breast Cancer After Mastectomy: Early Outcomes of a Prospective Clinical Trial
- (2013) Shannon M. MacDonald et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
- (2013) Kevin S. Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
- Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Alison W. Loren et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Reducing Local Therapy in Patients Responding to Preoperative Systemic Therapy: Are We Outsmarting Ourselves?
- (2013) Lawrence B. Marks et al. JOURNAL OF CLINICAL ONCOLOGY
- Locoregional Radiotherapy in Patients With Breast Cancer Responding to Neoadjuvant Chemotherapy: A Paradigm for Treatment Individualization
- (2013) Julia White et al. JOURNAL OF CLINICAL ONCOLOGY
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
- (2013) Joanne S Haviland et al. LANCET ONCOLOGY
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of axillary lymph node status in male breast carcinoma
- (2012) C. Vaysse et al. ANNALS OF ONCOLOGY
- Evolving trends in the initial locoregional management of male breast cancer
- (2012) Scott V. Bratman et al. BREAST
- Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
- (2012) Holm Eggemann et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer
- (2012) Rin Yamaguchi et al. HUMAN PATHOLOGY
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects
- (2011) N. Pemmaraju et al. ANNALS OF ONCOLOGY
- Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
- (2011) Makiko Ono et al. BREAST CANCER RESEARCH AND TREATMENT
- A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
- (2011) Abeer M. Shaaban et al. BREAST CANCER RESEARCH AND TREATMENT
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- The Impact of Post-Mastectomy Radiation Therapy on Male Breast Cancer Patients—A Case Series
- (2011) Edward Yu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in therapeutic strategies in Chinese male patients with breast cancer: 40 years of experience in a single institute
- (2010) Fei-Fei Zhou et al. BREAST
- Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer
- (2010) Maurizio Callari et al. BREAST CANCER RESEARCH AND TREATMENT
- Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
- (2010) Larissa A. Korde et al. JOURNAL OF CLINICAL ONCOLOGY
- Histological types of breast cancer: How special are they?
- (2010) Britta Weigelt et al. Molecular Oncology
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- (2010) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aromatase inhibition in male breast cancer patients: biological and clinical implications
- (2009) J. Doyen et al. ANNALS OF ONCOLOGY
- Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
- (2009) B. Cutuli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer in Men-Should Aromatase Inhibitors Become First-Line Hormonal Treatment?
- (2008) Ina C. Nordman et al. Breast Journal
- Sentinel Lymph Node Biopsy Is Successful and Accurate in Male Breast Carcinoma
- (2008) Laurie W. Flynn et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment
- (2008) Hironori Hayashi et al. Breast Cancer
- Second cancers in patients with male breast cancer: a literature review
- (2008) Tal Grenader et al. Journal of Cancer Survivorship
- Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: Evidence from 261 cases in Israel, 1976–1999
- (2007) Gabriel Chodick et al. European Journal of Medical Genetics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started